Herbs and the kidney

Barrett, 1999, Assessing the risks and benefits of herbal medicine, Altern Ther Health Med, 5, 40 De Smet, 2002, Herbal remedies, N Engl J Med, 347, 2046, 10.1056/NEJMra020398 Jha, 2003, Nephropathy associated with animal, plant, and chemical toxins in the tropics, Semin Nephrol, 23, 49, 10.1053/snep.2003.50003 Huxtable, 1990, The harmful potential of herbal and other plant products, Drug Saf, 5, S126, 10.2165/00002018-199000051-00020 Marcus, 2002, Botanical medicines—The need for new regulations, N Engl J Med, 347, 2073, 10.1056/NEJMsb022858 Ojogwu, 1983, Renal failure and hypertension in tropical Africa—A pre-dialysis experience from Nigeria, East Afr Med J, 60, 478 Randeree, 1995, Acute renal failure in pregnancy in South Africa, Ren Fail, 17, 147, 10.3109/08860229509026251 Seedat, 1978, Acute renal failure among blacks and Indians in South Africa, S Afr Med J, 54, 427 Adelekun, 1999, The pattern of acute toxic nephropathy in Ife, Nigeria, West Afr J Med, 18, 60 Kadiri, 1992, The causes and course of acute tubular necrosis in Nigerians, Afr J Med Med Sci, 21, 91 Gold, 1980, Acute renal failure from herbal and patent remedies in blacks, Clin Nephrol, 14, 28 Dukes, 1969, Acute renal failure in Central Africa. The toxic effects of traditional African medicine, Cent Afr J Med, 15, 71 Otieno, 1991, Acute renal failure following the use of herbal remedies, East Afr Med J, 68, 993 Seedat, 1993, Acute renal failure in the black population of South Africa, Int J Artif Organs, 16, 10.1177/039139889301601201 Seedat, 1971, Acute renal failure from Callilepsis laureola, S Afr Med J, 45 Luyckx, 2002, Herbal remedy-associated acute renal failure secondary to Cape aloes, Am J Kidney Dis, 39, E13, 10.1053/ajkd.2002.31424 Gold, 2001, Herbal-drug therapy interactions, Curr Opin Clin Nutr Metab Care, 4, 29, 10.1097/00075197-200101000-00006 Lin, 1994, Flavonoid-induced acute nephropathy, Am J Kidney Dis, 23, 433, 10.1016/S0272-6386(12)81008-0 Molhuysen, 1950, A liquorice extract with deoxycortone-like action, Lancet, 2, 381, 10.1016/S0140-6736(50)91341-9 Stewart, 1987, Mineralocorticoid activity of liquorice, Lancet, 2, 821, 10.1016/S0140-6736(87)91014-2 Funder, 1988, Mineralocorticoid action, Science, 243, 583, 10.1126/science.2845584 De Klerk, 1997, Lesson of the week, BMJ, 314, 731, 10.1136/bmj.314.7082.731 Winslow, 1998, Herbs as medicines, Arch Intern Med, 158, 2192, 10.1001/archinte.158.20.2192 Walker, 1994, Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess, Endocrinol Metab Clin North Am, 23, 359, 10.1016/S0889-8529(18)30102-6 Delcroix, 1985, Proximal tubulopathy in licorice poisoning, Presse Med, 14, 2346 Chan, 1992, Hospital admissions due to adverse reactions to Chinese herbal medicines, J Trop Med Hyg, 95, 296 Tomlinson, 2000, Toxicity of complementary therapies, J Clin Pharmacol, 40, 451, 10.1177/00912700022009206 Izumotani, 1993, An adult case of Fanconi syndrome due to a mixture of Chinese crude drugs, Nephron, 65, 137, 10.1159/000187455 Tanaka, 2001, Outbreak of Chinese herb nephropathy in Japan, Intern Med, 40, 296, 10.2169/internalmedicine.40.296 1997 1993, Illnesses and injuries associated with the use of selected dietary supplements Powell, 1998, Ma-huang strikes again, Am J Kidney Dis, 32, 153, 10.1053/ajkd.1998.v32.pm9669437 Haller, 2000, Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids, N Engl J Med, 343, 1833, 10.1056/NEJM200012213432502 Djibo, 2000, [Acute intoxication with “sobi-lobi” (Datura). Four cases in Niger], Bull Soc Pathol Exot, 93, 294 Chan, 1994, Anticholinergic poisoning from Chinese herbal medicines, Aust N Z J Med, 24, 317, 10.1111/j.1445-5994.1994.tb02182.x Harkins, 2000, What's the use of cranberry juice?, Age Ageing, 29, 9, 10.1093/ageing/29.1.9 Bodel, 1959, Cranberry juice and the antibacterial action hippuric acid, J Lab Clin Med, 54, 881 Jackson, 1997, Effect of cranberry juice on urinary pH in older adults, Home Health Nurs, 15, 199, 10.1097/00004045-199703000-00007 Zafriri, 1989, Inhibitory activity of cranberry juice on adherence of type I and type P fimbriated Escherichia coli to eukaryotic cells, Antimicrob Agents Chemother, 33, 92, 10.1128/AAC.33.1.92 Ofek, 1991, Anti-Escherichia coli adhesin activity of cranberry and blueberry juices, N Engl J Med, 324, 1599, 10.1056/NEJM199105303242214 Jepson, 2004, Cranberries for preventing urinary tract infection, Cochrane Database Syst Rev, 1, 10.1002/14651858.CD001321.pub3 Terris, 2001, Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis, Urology, 57, 26, 10.1016/S0090-4295(00)00884-0 Hilepo, 1997, Acute renal failure caused by “cat's claw” herbal remedy in a patient with systemic lupus erythematosus, Nephron, 77, 361, 10.1159/000190304 Wu, 1996, Multiple tubular dysfunction induced by mixed Chinese herbal medicines containing cadmium, Nephrol Dial Transplant, 11, 867, 10.1093/oxfordjournals.ndt.a027417 Wood, 1990, Acute dichromate poisoning after use of traditional purgatives. A report of 7 cases, S Afr Med J, 77, 640 Diamond, 1994, Acute interstitial nephritis following use of tung shueh pills, Am J Kidney Dis, 24, 219, 10.1016/S0272-6386(12)80186-7 Segasothy, 1991, Illicit herbal preparation containing phenylbutazone causing analgesic nephropathy, Nephron, 59, 166, 10.1159/000186543 Sir Hashim, 1992, Poisoning from henna dye and para-phenylenediamine mixtures in children in Khartoum, Ann Trop Paediatr, 12, 3, 10.1080/02724936.1992.11747539 Bourquia, 1988, Systemic toxicity of paraphenylenediamine, Presse Med, 17, 1798 Averbukh, 1989, Rhabdomyolysis and acute renal failure induced by paraphenylenediamine, Hum Toxicol, 8, 345, 10.1177/096032718900800502 Shemesh, 1995, Rhabdomyolysis in paraphenylenediamine intoxication, Vet Hum Toxicol, 37, 244 Saito, 1990, [Rhabdomyolysis due to paraphenylenediamine (hair dye)—Report of an autopsy case], Nippon Hoigaku Zasshi, 44, 469 Zaid, 2002, Takaout induced acute renal failure, Semin Uronephrol Pitie Salpetriere, 28, 140 Vanherweghem, 1993, Rapidly progressive interstitial renal fibrosis in young women, Lancet, 341, 387, 10.1016/0140-6736(93)92984-2 Vanhaelen, 1994, Identification of aristolochic acid in Chinese herbs, Lancet, 343, 174, 10.1016/S0140-6736(94)90964-4 Vanherweghem, 1998, Misuse of herbal remedies, J Altern Complement Med, 4, 9, 10.1089/acm.1998.4.1-9 Cosyns, 2003, Aristolochic acid and “Chinese herbs nephropathy”, Drug Saf, 26, 33, 10.2165/00002018-200326010-00004 Pourrat, 1994, [Nephropathy associated with Chinese herbal drugs, Presse Med, 23, 1669 Stengel, 1998, End-stage renal insufficiency associated with Chinese herbal consumption in France, Nephrologie, 19, 15 Pena, 1996, Rapidly progressive interstitial renal fibrosis due to a chronic intake of a herb (Aristolochia pistolochia) infusion, Nephrol Dial Transplant, 11, 1359, 10.1093/ndt/11.7.1359 Lord, 1999, Nephropathy caused by Chinese herbs in the UK, Lancet, 354, 481, 10.1016/S0140-6736(99)03380-2 Cronin, 2002, Aristolochic acid as a causative factor in a case of Chinese herbal nephropathy, Nephrol Dial Transplant, 17, 524, 10.1093/ndt/17.3.524 Yu, 2003, [Chinese herbs-induced renal failure with Fanconi syndrome, Zhonghua Nei Ke Za Zhi, 42, 110 Yang, 2000, Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs, Am J Kidney Dis, 35, 313, 10.1016/S0272-6386(00)70343-X Chang, 2001, Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications, Am J Nephrol, 21, 441, 10.1159/000046647 Tanaka, 2000, The characteristic pattern of aminoaciduria in patients with aristolochic acid-induced Fanconi syndrome, Clin Nephrol, 54, 198 Ng, 1998, Interstitial renal fibrosis in a young woman, Nephrol Dial Transplant, 13, 2115, 10.1093/ndt/13.8.2115 Meyer, 2000, Chinese herb nephropathy, BUMC Proc, 13, 334 Tanaka, 2000, Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome, Clin Nephrol, 53, 301 Krumme, 2001, Reversible Fanconi syndrome after ingestion of a Chinese herbal “remedy” containing aristolochic acid, Nephrol Dial Transplant, 16, 400, 10.1093/ndt/16.2.400 Yang, 2002, Aristolochic acid-induced Fanconi's syndrome and nephropathy presenting as hypokalemic paralysis, Am J Kidney Dis, 39, E14, 10.1053/ajkd.2002.31425 Hoshino, 2003, Chinese herbs and bone disease, Intern Med, 42, 345, 10.2169/internalmedicine.42.345 Kabanda, 1995, Low molecular weight proteinuria in Chinese herbs nephropathy, Kidney Int, 48, 1571, 10.1038/ki.1995.449 Nortier, 1997, Proximal tubular injury in Chinese herbs nephropathy, Kidney Int, 51, 288, 10.1038/ki.1997.35 Cosyns, 1994, Chinese herbs nephropathy, Kidney Int, 45, 1680, 10.1038/ki.1994.220 Depierreux, 1994, Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs, Am J Kidney Dis, 24, 172, 10.1016/S0272-6386(12)80178-8 Cosyns, 1994, Urothelial malignancy in nephropathy due to Chinese herbs, Lancet, 344, 188, 10.1016/S0140-6736(94)92786-3 Cosyns, 1999, Urothelial lesions in Chinese-herb nephropathy, Am J Kidney Dis, 33, 1011, 10.1016/S0272-6386(99)70136-8 Vanherweghem, 1995, Chinese herbs nephropathy and renal pelvic carcinoma, Nephrol Dial Transplant, 10, 270 Nortier, 2000, Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi), N Engl J Med, 342, 1686, 10.1056/NEJM200006083422301 Mengs, 1987, Acute toxicity of aristolochic acid in rodents, Arch Toxicol, 59, 328, 10.1007/BF00295084 Jackson, 1964, Aristolochic acid (NSC-50413), Cancer Chemother, 42, 35 Mengs, 1982, The carcinogenic action of aristolochic acid in rats, Arch Toxicol, 51, 107, 10.1007/BF00302751 Schmeiser, 1996, Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herb nephropathy, Cancer Res, 1996, 2025 Martinez, 2002, Progression rate of Chinese herb nephropathy, Nephrol Dial Transplant, 17, 408, 10.1093/ndt/17.3.408 Cosyns, 2001, Chronic aristolochic acid toxicity in rabbits, Kidney Int, 59, 2164, 10.1046/j.1523-1755.2001.00731.x Debelle, 2002, Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats, J Am Soc Nephrol, 13, 431, 10.1681/ASN.V132431 Woelk, 2000, Comparison of St John's wort and imipramine for treating depression, BMJ, 321, 536, 10.1136/bmj.321.7260.536 Ernst, 2002, The risk-benefit profile of commonly used herbal therapies, Ann Intern Med, 136, 42, 10.7326/0003-4819-136-1-200201010-00010 Ernst, 1999, Second thoughts about safety of St John's wort, Lancet, 354, 2014, 10.1016/S0140-6736(99)00418-3 Johne, 1999, Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum), Clin Pharmacol Ther, 66, 338, 10.1053/cp.1999.v66.a101944 Piscitelli, 2000, Indinavir concentrations and St John's wort, Lancet, 355, 547, 10.1016/S0140-6736(99)05712-8 Yue, 2000, Safety of St John's wort (Hypericum perforatum), Lancet, 355, 576, 10.1016/S0140-6736(05)73227-X Nebel, 1999, Potential metabolic interaction between St. John's wort and theophylline, Ann Pharmacother, 33, 502, 10.1345/aph.18252 Bolley, 2002, Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort, Transplantation, 73, 1009, 10.1097/00007890-200203270-00035 Cott, 1995, Natural product formulation available in Europe for psychotropic indication, Psychopharmacol Bull, 31, 745 Sastre, 1998, A Ginkgo biloba extract (EGb 761) prevents mitochondrial aging by protecting against oxidative stress, Free Radic Biol Med, 15, 298, 10.1016/S0891-5849(97)00228-1 Rowin, 1996, Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion, Neurology, 46, 1775, 10.1212/WNL.46.6.1775 Matthews, 1998, Association of Ginkgo biloba with intracerebral hemorrhage, Neurology, 50, 1933, 10.1212/WNL.50.6.1933 Gilbert, 1997, Ginkgo biloba, Neurology, 48, 1137, 10.1212/WNL.48.4.1137 Chung, 1987, Effect of ginkgolide mixture in antagonizing skin and platelet response to platelet activating factor in man, Lancet, 1, 248, 10.1016/S0140-6736(87)90066-3 Meisel, 2003, Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen, Atherosclerosis, 167, 367, 10.1016/S0021-9150(03)00015-7 Abebe, 2002, Herbal medication, J Clin Pharm Ther, 27, 391, 10.1046/j.1365-2710.2002.00444.x Vaes, 2000, Interactions of warfarin with garlic, ginger, ginkgo, or ginseng, Ann Pharmacother, 34, 1478, 10.1345/1542-6270(2000)034<1478:IOWWGG>2.0.CO;2 Williamson, 2001, Synergy and other interactions in phytomedicines, Phytomedicine, 8, 401, 10.1078/0944-7113-00060 Shinozuka, 2002, Feeding of Ginkgo biloba extract (GBE) enhances gene expression of hepatic cytochrome P-450 and attenuates the hypotensive effect of nicardipine in rats, Life Sci, 70, 2783, 10.1016/S0024-3205(02)01530-8 Gurley, 2002, Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans, Clin Pharmacol Ther, 72, 276, 10.1067/mcp.2002.126913 Foote, 1998, Medicinal herb use and the renal patient, J Ren Nutr, 8, 40, 10.1016/S1051-2276(98)90036-X Mueller, 2000, Noni juice (Morinda citrifolia), Am J Kidney Dis, 35, 310, 10.1016/S0272-6386(00)70342-8 Seedat, 1993, Acute renal failure in blacks and Indians in South Africa—Comparison after 10 years, Nephron, 64, 198, 10.1159/000187314